Projects per year
- 1 - 50 out of 1,149 results
Search results
-
Active
Evaluating Telementoring to Initiate a Multidimensional Diabetes Program for Latino(A)s in Community Clinics: A Randomized Clinical
8/16/22 → 7/31/26
Project: Other project
-
-
2/2 - Mongolian Center for Environmental & Occupational Health - U.S.
6/1/22 → 2/28/27
Project: Other project
-
-
-
-
-
-
One-Health Approach to Study Human Fasciola Hepatica Transmission and Inform Strategic Control
4/22/22 → 3/31/27
Project: Other project
-
-
A Prospective Observational Registry of Patients Treated with LUPKYNIS (voclosporin) in the US
4/11/22 → 4/10/27
Project: Other project
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Surveillance for Emerging Avian Influenza Viruses Study in Vietnam
1/27/22 → 8/19/23
Project: Other project
-
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Concomitant Administration of Either 23-Valent Pneumococcal Polysaccharide Vaccine or 15-Valent Pneumococcal Conjugate Vaccine
Merck Sharp & Dohme Corporation
10/29/21 → 10/28/26
Project: Other project
-
-
-
Alnylam Pharmaceuticals, Inc. - 0306060, Assessing Patients' Experiences With Acute Hepatic Porphyria: Exit Interviews (Pro00053618)
10/6/21 → 10/5/24
Project: Other project
-
Epigenetic control of mucosal IRF1/IFN-III antiviral response by enhancer-like promoter and its coding lncRNA
9/24/21 → 11/30/23
Project: Other project
-
-
Part B: Hospital Preparedness Program Ebola Preparedness and Response Activities Grant Program
9/23/21 → 6/14/23
Project: Other project
-
-
ELEVATE, a global observational longitudinal prospective registry of patients with acute hepatic porphyria (AHP)
8/20/21 → 8/19/26
Project: Other project
-
CPR-2218: A Multi-Center Registry Evaluating Participants Who Received CanGaroo Envelope or No Envelope During CIED Implantation
7/26/21 → 7/25/26
Project: Other project
-
-
RE: Porphyria Rare Disease Clinical Research Consortium (RDCRC)
5/14/21 → 6/30/23
Project: Other project
-
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction e 40% (L
Bayer HealthCare Pharmaceuticals
1/21/21 → 1/20/26
Project: Other project
-
HIV Prevention Program
Texas Department of State Health Service
1/1/21 → 8/31/23
Project: Other project
-